The immune-suppressing drug used to prevent organ rejection in transplant patients, rapamycin, has been reported to reduce bone loss, inflammation, and changes to oral bacteria in older mice with periodontal diseases, according to a recent…
The American Dental Hygienists’ Association (ADHA) released its “Interim Guidance on Returning to Work” in early May, as many states began allowing the reopening of dental practices for elective treatment.
Affecting the quality of life for more than 10 million Americans, temporomandibular disorders (TMDs) are musculoskeletal conditions associated with pain and dysfunction of the temporomandibular joint (TMJ) and muscles of mastication.
Clinical trials on an inhaled type of the antiviral treatment remdesivir will start on patients with COVID-19 beginning in August. Phase 1 trials on healthy volunteers will begin the week of June 22. Made by Gilead Sciences Inc, remdesivir…
Coronaviruses (CoV) are a large family of viruses that cause illness ranging from respiratory infections (including the common cold to flu-like or pneumonia symptoms), as well as gastrointestinal symptoms—all which may or may not appear and…
The Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center, led by the University of Michigan School of Dentistry (U-M), has received a $31.4 million grant from the National Institute of Dental and Craniofacial Research to continue…
European researchers suggest that blood type may impact the risk of acquiring COVID-19 as well as the severity of symptoms once infected. Published in the New England Journal of Medicine, the study examined the genes of more than 4,000…
